Armelle Luscan

PRC2 loss amplifies Ras-driven transcription and confers sensitivity to BRD4-based therapies

Thomas De Raedt, Eline Beert, Éric Pasmant et al. · Nature · 2014 · 461 citations

Transcriptional Regulation, Cell Regulation, Cell Signaling +12

<i>NF1</i> Molecular Characterization and Neurofibromatosis Type I Genotype-Phenotype Correlation: The French Experience

Audrey Sabbagh, Éric Pasmant, Apolline Imbard et al. · Human Mutation · 2013 · 173 citations · Full text

Mutations in <i>SETD2</i> cause a novel overgrowth condition

Armelle Luscan, Ingrid Laurendeau, Valérie Malan et al. · Journal of Medical Genetics · 2014 · 141 citations

Neurofibromatosis type 1 molecular diagnosis: what can NGS do for you when you have a large gene with loss of function mutations?

Éric Pasmant, Béatrice Parfait, Armelle Luscan et al. · European Journal of Human Genetics · 2014 · 119 citations · Full text

Large Gene, Molecular Diagnosis, Mendelian Disorder +13

Competitive allele specific TaqMan PCR for KRAS, BRAF and EGFR mutation detection in clinical formalin fixed paraffin embedded samples

Audrey Didelot, Delphine Le Corre, Armelle Luscan et al. · Experimental and Molecular Pathology · 2012 · 106 citations

Allelic Variant, Engineering, Medicine +11